航錦科技(000818.SZ):擬1500萬參投創投基金 將投向半導體相關產業
格隆匯12月9日丨航錦科技(000818.SZ)公佈,公司於近日與武漢澤森長盛創業投資基金管理有限公司(簡稱“武漢澤森長盛”)及其他投資合作方簽署了《蘇州澤森匯湧創業投資合夥企業(有限合夥)合夥協議》,共同投資蘇州澤森匯湧創業投資合夥企業(有限合夥)(簡稱“蘇州澤森匯湧”)。
蘇州澤森匯湧註冊認繳出資額為人民幣1.321億元,其中武漢澤森長盛認繳出資10萬元,系普通合夥人。公司擬以自有資金認繳出資1500萬元,佔總認繳出資額的11.36%,為有限合夥人。蘇州澤森匯湧將投向半導體相關產業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.